The Story Behind Emisha

Emisha was founded with a simple belief: patients deserve faster answers.

After experiencing firsthand how slow, high-risk drug development costs patients precious time, we committed to building a platform capable of changing the equation.

Our work is personal - and our mission is urgent.

Our Mission

To eliminate avoidable clinical failures by giving drug developers a scientifically rigorous way to understand how therapies will perform before testing them in real patients - Every new therapy touches A10M before it touches a human.

Drug development is too slow, too expensive, and too uncertain. We built Emisha to change that.

Who We Are

Emisha is a health-tech and biosimulation company combining:

• Mechanistic systems biology

• PK/PD modeling

• Machine learning

• Real-world patient data

• Clinical operations expertise

We integrate these domains into a continuously improving simulation platform designed to derisk early-stage development and enable patients to receive therapies that work - faster.

Our Three Core Pillars

1. Patient Support Program (PSP)

White-glove enrollment, adherence, and outcomes tracking built to deliver real-time, high-quality Real World Data.

2. Medical Record Normalization

Automated pipelines convert messy clinical documents into structured, standardized formats ready for modeling and regulatory use.

3. A10M™ Digital Twin

A predictive simulation engine that models individual patient physiology, drug behavior, and population variability to forecast safety and efficacy.